These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37139691)

  • 1. Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies.
    van der Vaart A; Eelderink C; van Beek AP; Bakker SJL; van Dijk PR; de Borst MH
    J Clin Endocrinol Metab; 2023 Sep; 108(10):e971-e978. PubMed ID: 37139691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
    Binnenmars SH; Hoogslag GE; Yeung SMH; Brouwers FP; Bakker SJL; van Gilst WH; Gansevoort RT; Navis G; Voors AA; de Borst MH
    J Am Heart Assoc; 2022 Aug; 11(15):e024952. PubMed ID: 35876420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.
    Ali FN; Falkner B; Gidding SS; Price HE; Keith SW; Langman CB
    J Pediatr; 2014 Oct; 165(4):738-43.e1. PubMed ID: 25063724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
    Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
    JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function.
    Zaheer S; de Boer IH; Allison M; Brown JM; Psaty BM; Robinson-Cohen C; Michos ED; Ix JH; Kestenbaum B; Siscovick D; Vaidya A
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1387-1395. PubMed ID: 28323987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.
    Montford JR; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
    Am J Nephrol; 2013; 37(3):183-90. PubMed ID: 23428834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males.
    Falkner B; Keith SW; Gidding SS; Langman CB
    J Am Soc Hypertens; 2017 Aug; 11(8):480-487. PubMed ID: 28456498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis.
    de Jong MA; Petrykiv SI; Laverman GD; van Herwaarden AE; de Zeeuw D; Bakker SJL; Heerspink HJL; de Borst MH
    Clin J Am Soc Nephrol; 2019 Jan; 14(1):66-73. PubMed ID: 30559106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
    Panwar B; Jenny NS; Howard VJ; Wadley VG; Muntner P; Kissela BM; Judd SE; Gutiérrez OM
    Stroke; 2015 Feb; 46(2):322-8. PubMed ID: 25563643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cross-sectional Study on Fibroblast Growth Factor 23 and Other Markers of Mineral Metabolism in Healthy Children in India.
    Chaturvedi S; Vijayakumar TS; Job V; Mahendri NV; Salusky I; Agarwal I
    Saudi J Kidney Dis Transpl; 2023 Mar; 34(2):147-153. PubMed ID: 38146724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.
    Kosk D; Kramer H; Luke A; Camacho P; Bovet P; Rhule JP; Forrester T; Wolf M; Sempos C; Melamed ML; Dugas LR; Cooper R; Durazo-Arvizu R
    J Bone Miner Metab; 2017 Nov; 35(6):666-674. PubMed ID: 27942978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.
    Kim HJ; Park M; Park HC; Jeong JC; Kim DK; Joo KW; Hwang YH; Yang J; Ahn C; Oh KH
    Perit Dial Int; 2016; 36(1):26-32. PubMed ID: 25185018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Cai X; Lee J; Scialla JJ; Bansal N; Sondheimer JH; Chen J; Hamm LL; Ricardo AC; Navaneethan SD; Deo R; Rahman M; Feldman HI; Go AS; Isakova T; Wolf M;
    JAMA Cardiol; 2016 Aug; 1(5):548-56. PubMed ID: 27434583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
    Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
    Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry.
    Eckberg K; Kramer H; Wolf M; Durazo-Arvizu R; Tayo B; Luke A; Cooper R
    Nephrol Dial Transplant; 2015 Apr; 30(4):630-5. PubMed ID: 25358495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort.
    Yeung SMH; Hoorn EJ; Rotmans JI; Gansevoort RT; Bakker SJL; Vogt L; de Borst MH
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.